Zahid Ahmad (@dr_zahid_ahmad) 's Twitter Profile
Zahid Ahmad

@dr_zahid_ahmad

Endocrinologist and Lipid Specialist at UT Southwestern; @halalpitmasters

ID: 951267439244922880

calendar_today11-01-2018 01:40:05

365 Tweet

478 Followers

496 Following

Dinesh Kalra, MD (@dineshkalra) 's Twitter Profile Photo

Great start to #nlasessions Atlanta with discussions on lower LDL-C levels times time duration is better, new therapeutics for Lp(a), CETPi, apoC3 and a great talks on FH, triglycerides Michael D. Shapiro Christie Ballantyne Alan Brown MD MHA FACC FNLA Zahid Ahmad

Great start to #nlasessions Atlanta with discussions on lower LDL-C levels times time duration is better, new therapeutics for Lp(a), CETPi, apoC3 and a great talks on FH, triglycerides <a href="/DrMichaelShapir/">Michael D. Shapiro</a> <a href="/CBallantyneMD/">Christie Ballantyne</a> <a href="/alanbrownmd/">Alan Brown MD MHA FACC FNLA</a> <a href="/Dr_Zahid_Ahmad/">Zahid Ahmad</a>
Christie Ballantyne (@cballantynemd) 's Twitter Profile Photo

Message from ⁦@ DrMarthaGulati⁩ ⁦ASPC⁩ Kevin Maki ⁦National Lipid Association⁩ How can we improve quality of lipid management unless we measure at least LDL-C? ⁦Salim Virani⁩ ⁦Dave Dixon, Professor & Chair @VCUPharmacy⁩ ⁦Dan Soffer⁩ ⁦ acc.org/Latest-in-Card…

Amy Faith Ho, MD MPH (@amyfaithho) 's Twitter Profile Photo

Q: Why are waits at emergency rooms so long? A: Because the rest of the healthcare system is failing. The patient did everything right, but the healthcare system did them so so so wrong. 🧵… They call their PCP, but can’t get an appointment. So they turn to the ER. They

Dr. James Underberg (@lipiddoc) 's Twitter Profile Photo

While I agree with the statement 👍 "evidence shows that statins reduce lipid levels in children with FH, and observational studies suggest that such treatment has long-term benefit for this condition" I struggle to understand how they can conclude that "FH is relatively rare"🙄

National Lipid Association (@nationallipid) 's Twitter Profile Photo

Join us 5/29 before the #NLASessions kick off for an exclusive deep dive into the world of TGs. The Mastering Triglycerides Masters Course is here to turn up the heat on hypertriglyceridemia mngmt Christie Ballantyne Zahid Ahmad Venkata Sandeep Akshintala Alan Brown MD MHA FACC FNLA lipid.org/mastering-trig…

Join us 5/29 before the #NLASessions kick off for an exclusive deep dive into the world of TGs. The Mastering Triglycerides Masters Course is here to turn up the heat on hypertriglyceridemia mngmt <a href="/CBallantyneMD/">Christie Ballantyne</a> <a href="/Dr_Zahid_Ahmad/">Zahid Ahmad</a> <a href="/V_Akshintala/">Venkata Sandeep Akshintala</a> <a href="/alanbrownmd/">Alan Brown MD MHA FACC FNLA</a>
lipid.org/mastering-trig…
JaredSpitzMD (@jspitz_md) 's Twitter Profile Photo

So excited for this! This is a great (and easy!) test to help better understand risk and what is going on with our patients. I know my apoB and Lp(a). Do you know yours? National Lipid Association Dan Soffer Thomas Dayspring

Dinesh Kalra, MD (@dineshkalra) 's Twitter Profile Photo

#NLA2024 honors its dedicated and passionate lipid specialists who are fighting the good fight to combat dyslipidemia and improve cardiometabolic health - Drs. Bart Duell, Kevin Maki, Florian Kronenberg, Don Wilson, Gina Lundberg MD FACC FAHA Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA Marlys Koschinsky Dan Soffer

#NLA2024 honors its dedicated and passionate lipid specialists who are fighting the good fight to combat dyslipidemia and improve cardiometabolic health - Drs. Bart Duell, Kevin Maki, Florian Kronenberg, Don Wilson, <a href="/gina_lundberg/">Gina Lundberg MD FACC FAHA</a> <a href="/carolkirkpat3/">Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA</a> <a href="/MarlysLPA/">Marlys Koschinsky</a> <a href="/dan_soffer/">Dan Soffer</a>
Eugenia Gianos MD (@eugeniagianos) 's Twitter Profile Photo

Don’t miss this year’s #FamilyHeartSummit#24! This is a truly inspiring conference with amazing clinicians, researchers and a unique element - the patient story told by patients themselves! Josh Knowles Roger Blumenthal Mary Mcgowan Lawrence Sperling Christie Ballantyne

National Lipid Association (@nationallipid) 's Twitter Profile Photo

You can still join Zahid Ahmad & our expert faculty this Friday for our 1 day Mastering TGs Course. Live stream the course from your home/office, get 8 hours of CME/CE, & improve your proficiency on the complexities of severe hypertriglyceridemia 👉lipid.org/mastering-trig…

National Lipid Association (@nationallipid) 's Twitter Profile Photo

Our Expert Clinical Consensus was just released providing an overview of the physiologic and clinical considerations regarding the role of apoB measurement to guide clinical care based on the available scientific evidence and expert opinion Dan Soffer Nicholas Marston Christie Ballantyne

Dinesh Kalra, MD (@dineshkalra) 's Twitter Profile Photo

Excellent National Lipid Association sessions today on importance of measuring ApoB, U/S for carotid plaque, CACS, CCTA for coronary plaque assessment in primary prevention #ARTCAP, polygenic risk scores, and lipid lowering in older pts (>75 yrs). Not to be missed! vijay nambi Michael Wilkinson

Excellent <a href="/nationallipid/">National Lipid Association</a> sessions today on importance of measuring ApoB, U/S for carotid plaque, CACS, CCTA for coronary plaque assessment in primary prevention #ARTCAP, polygenic risk scores, and lipid lowering in older pts (&gt;75 yrs). Not to be missed! <a href="/vijay_nambi/">vijay nambi</a> <a href="/MWilkinsonMD/">Michael Wilkinson</a>
Dr Gary McGowan (@drgarymcgowan) 's Twitter Profile Photo

40 Years On: Still Arguing About Statins 🗣️ In the 1980s, some of the ongoing debate related to Statins was starting to settle. The early days of cholesterol-lowering was rejected not by contrarians, but by mainstream cardiologists. One of the core trials to change the tune was

40 Years On: Still Arguing About Statins 🗣️

In the 1980s, some of the ongoing debate related to Statins was starting to settle. The early days of cholesterol-lowering was rejected not by contrarians, but by mainstream cardiologists. One of the core trials to change the tune was